Keyphrases
Antibody-based
100%
Binding Affinity
10%
Binding Specificity
20%
Biodistribution
10%
Cancer Imaging
100%
Cancer Treatment Planning
10%
Competitive Binding Assay
10%
Conjugation
10%
Deferoxamine
90%
Detailed Mechanism
10%
Expression Level
10%
Flow Cytometry
10%
High Specific Activity
10%
Histology
10%
Labeled Antibody
10%
LNCaP
10%
Major Organs
10%
Microscopic Study
10%
Monoclonal Antibody
10%
Muscle Ratio
10%
Oncologists
10%
Positron Emission Tomography
100%
Positron Emission Tomography Tracers
10%
Quantitative Imaging
10%
Quantitative Positron Emission Tomography
10%
Radiochemical Yield
10%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Tumor
50%
Tumor Contrast
10%
Tumor Progression
10%
Tumor Uptake
30%
U87MG
20%
Urokinase-type Plasminogen Activator
100%
Western Blotting
10%
Zirconium-89 (89Zr)
90%
Medicine and Dentistry
Binding Affinity
10%
Biodistribution
10%
Cancer Treatment Planning
10%
Competitive Binding Assay
10%
Deferoxamine
90%
Flow Cytometry
10%
Malignant Neoplasm
100%
Monoclonal Antibody
10%
Neoplasm
90%
Oncologist
10%
Pharmacological Blocking
10%
Positron Emission Tomography
100%
Quantitative Imaging
10%
Radioactive Tracer
10%
Receptor
10%
Tumor Progression
10%
Urokinase
100%
Western Blotting
10%
Zirconium 89
90%
Pharmacology, Toxicology and Pharmaceutical Science
Biodistribution
10%
Deferoxamine
90%
Flow Cytometry
10%
Malignant Neoplasm
100%
Monoclonal Antibody
10%
Neoplasm
90%
Pharmacological Blocking
10%
Receptor
10%
Tracer
10%
Tumor Growth
10%
Urokinase
100%
Western Blot
10%
Zirconium 89
90%
Immunology and Microbiology
Binding Affinity
20%
Binding Competition
20%
Immunology
100%
Monoclonal Antibody
20%
Pharmacological Blocking
20%
Positron Emission Tomography
100%
Western Blot
20%